Purpose-built AI interprets every result in context, explains what matters, recommends guideline-based follow-up tests, and tracks trends over time.
TAMPA, FL, UNITED STATES, July 27, 2026 /EINPresswire.com/ -- Plainvue.AI today announced the launch of its proprietary lab-interpretation platform, designed to turn complex lab test results into a clear, actionable picture of a person’s health. Plainvue analyzes each result alongside related tests, explains the findings in plain language, recommends appropriate follow-up testing, and tracks changes over time so meaningful patterns come into view.
The platform addresses a familiar problem: lab results often arrive as a page of numbers with little explanation of what matters or what to do next. Most abnormal values cannot be interpreted alone—more than 83% of lab tests depend on at least one other value for proper interpretation. Specialist doctors have known for years that individual labs cannot be acted upon in isolation—the whole picture must be understood through evaluating each test result in context of all other interdependent and related tests. Plainvue’s AI engine is that specialist.
Plainvue is bucking the trend of simply attaching an AI chat box to a lab test report. Its purpose-built healthcare AI engine evaluates abnormal results in context of closely related labs and makes recommended follow-up interpretations based on published clinical literature and standard-of-care guidance. The resulting next steps are clear—all without the HIPAA concerns about sending patient data to third-party AI clouds.
The launch comes as consumers increasingly turn to AI for health information. More than 40 million people a day now ask ChatGPT health-related questions, and roughly one in three U.S. adults have used an AI chatbot for health information in the past year. Among those users, 41% report uploading personal medical information, including lab results, for explanation (OpenAI, 2026; KFF Tracking Poll on Health Information and Trust, 2026).
Yet most adults say they cannot reliably judge whether an AI health answer is accurate, while 77% are concerned about the privacy of the medical information they share with these tools (KFF, 2026). Plainvue was built for that gap.
Plainvue was founded by Jim Norman, MD, a physician and serial entrepreneur who previously founded Healthline and Talix. Norman also pioneered a minimally invasive parathyroid surgical technique, built and sold the world’s highest-volume endocrine surgery practice, and founded the Hospital for Endocrine Surgery. Plainvue brings that clinical and operating experience to one goal: making lab results understandable and actionable.
“People are already asking AI about their health—they just don’t know if they can trust the answers or what the next steps should be,” said Dr. Norman. “We built Plainvue to bridge that gap: every interpretation and recommendation is grounded in published literature and traceable to its source.”
At the core of Plainvue is a patent-pending interdependency engine that maps how lab analytes relate to one another. When a result is abnormal, the platform recommends the primary and secondary follow-up tests a specialist would typically order, presents the reasoning in plain language, and gives the patient a clear next step. Patients can ask questions about their findings and share results with their physicians.
By interpreting results in context and over time, Plainvue turns a one-time snapshot into a trajectory so patients can see how their overall health is changing, their individual organ systems are changing, and their biologic age is progressing.
Unlike general-purpose chatbots layered onto lab reports, Plainvue runs on an internal, purpose-built model for faster, more consistent interpretation, with no patient data robotically sent to third-party AI clouds.
“Patients get handed a page of numbers and go home to Google it. That’s not good enough,” Norman said. “Plainvue reads every test in context, explains what the results mean together, and points to the exact follow-up a specialist would typically consider.”
Plainvue partners with laboratory providers to offer the platform as a co-branded patient experience—giving patients clearer answers while surfacing medically indicated follow-up testing that too often goes undone.
Plainvue will soon launch its consumer application that brings all of a person’s health information into one place—not just their lab tests. The AI engine will interpret all types of results together to get the big picture and provide clear, sourced answers to questions about their overall health.
“I’ve spent my career proving that when specialists go deep on one problem, patients get better answers. Plainvue does that for the lab report,” said Dr. Norman.
About Plainvue
Plainvue is a healthcare AI company whose proprietary, purpose-built model interprets lab results in context, explains them in plain language, tracks them over time, and surfaces the follow-up testing called for by standard-of-care guidance making lab tests understandable, contextualized, and actionable. Learn more at plainvue.ai.
Diana Van Leuven
The VAN LEUVEN Company
+1 314-409-9051
Visit us on social media:
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
